ONXX Onyx Pharmaceuticals, Inc. (MM)

Onyx Pharmaceuticals to Present at UBS Global Life Sciences Conference RICHMOND, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the UBS Global Life Science conference on Monday, September 27, at 1:30 p.m. Eastern Time. Interested parties may access a live webcast of the presentation at: http://event.streamx.us/event/default.asp?event=ubs20040927 It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through October 27. Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at http://www.onyx-pharm.com/. DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Julie Wood of Onyx Pharmaceuticals, Inc., +1-510-262-8757 Web site: http://www.onyx-pharm.com/

Copyright